30 November 2009
Palamon Capital Partners provides growth capital for Polikum

Back to press index  |  Download press release

Palamon Capital Partners (“Palamon”), one of Europe’s leading mid-market private equity firms, has agreed to provide growth capital to Polikum GmbH (“Polikum” or “the Company”), a German operator of health clinics.

Polikum, operating in the growing healthcare sector, provides a broad range of outpatient medical treatments in a cost efficient way.  Through the development of a multidisciplinary approach to outpatient care, Polikum’s business model benefits local physicians and feedback from patients consistently demonstrates a high level of satisfaction.  The Company currently operates three large health clinics in Berlin and will be opening a number of similar clinics in other major German cities over the next few years.   

Polikum was founded in 2004 by Dr Wolfram Otto, a practicing physician, who continues to build the business as CEO and majority owner.  Dr Otto is supported by an outstanding team of local physicians, who are focused on patient care, and a central management team, who focus on developing the business. 

Commenting on the transaction, Holger Kleingarn, Partner at Palamon, said:  “The outpatient healthcare sector is exceptionally well positioned to provide a high-quality service to patients and at the same time keep healthcare spending under control.  Polikum has developed a unique business model to fulfil patient and market needs.  It is well positioned to become a leading operator in the outpatient sector in Germany.”

Dr Wolfram Otto, Founder and CEO of Polikum commented:  “The opportunity in the outpatient healthcare sector in Germany is significant and we are excited to have attracted Palamon to support the future growth of Polikum.  We are very confident that Polikum, in partnership with local physicians, will be able to provide an even broader range of support to patients in Berlin and other German cities going forward.”

This transaction marks the twelfth investment of the Firm’s second fund, Palamon European Equity, II, which has over 55% of its €670 million invested.  Aligned with its investment thesis in healthcare, the Firm earlier this year concluded an investment in Grupo SAR, one of Spain’s leading providers of care to the elderly.

Back to press index  |  Download press release